4-Methoxyphenyl-4-(2-Oxo-3-propylimidazolidin-1-yl)benzenesulfonate

ID: ALA4104279

PubChem CID: 88909651

Max Phase: Preclinical

Molecular Formula: C19H22N2O5S

Molecular Weight: 390.46

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCN1CCN(c2ccc(S(=O)(=O)Oc3ccc(OC)cc3)cc2)C1=O

Standard InChI:  InChI=1S/C19H22N2O5S/c1-3-12-20-13-14-21(19(20)22)15-4-10-18(11-5-15)27(23,24)26-17-8-6-16(25-2)7-9-17/h4-11H,3,12-14H2,1-2H3

Standard InChI Key:  HBSMNUTUYZOFES-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    8.7415   -6.7521    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.1542   -7.4620    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    9.5626   -6.7497    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0355   -7.8788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0344   -8.6984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7424   -9.1073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4521   -8.6979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4492   -7.8752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7406   -7.4700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8668   -7.8644    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.5860   -7.4764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2785   -7.9059    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9971   -7.5185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0212   -6.7008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3205   -6.2720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6047   -6.6618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3263   -9.1064    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5827   -8.7767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0355   -9.3836    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4435  -10.0917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2429   -9.9223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4125   -7.9775    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2228   -9.2975    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7420   -9.9583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9293   -9.8722    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7398   -6.3118    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.7623   -5.4949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  8  2  1  0
  2 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
  5 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 17  1  0
 18 22  2  0
 19 23  1  0
 23 24  1  0
 24 25  1  0
 14 26  1  0
 26 27  1  0
M  END

Associated Targets(Human)

M21 (1715 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 390.46Molecular Weight (Monoisotopic): 390.1249AlogP: 3.11#Rotatable Bonds: 7
Polar Surface Area: 76.15Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.96CX LogD: 2.96
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.68Np Likeness Score: -1.23

References

1. Fortin S, Charest-Morin X, Turcotte V, Lauvaux C, Lacroix J, Côté MF, Gobeil S, C-Gaudreault R..  (2017)  Activation of Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonates Prodrugs by CYP1A1 as New Antimitotics Targeting Breast Cancer Cells.,  60  (12): [PMID:28535350] [10.1021/acs.jmedchem.7b00343]

Source